Consolidated Statement Of Cash Flows

Tri Chemical Laboratories Inc. - Filing #7265969

Concept As at
2025-01-31
2024-02-01 to
2025-01-31
As at
2024-01-31
2023-02-01 to
2024-01-31
As at
2023-01-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
3,959,535,000 JPY
1,973,202,000 JPY
Interest and dividends received
392,882,000 JPY
2,542,901,000 JPY
Income taxes paid
-653,492,000 JPY
-1,520,343,000 JPY
Interest paid
-23,815,000 JPY
-23,744,000 JPY
Net cash provided by (used in) operating activities
3,675,110,000 JPY
2,972,015,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-3,069,362,000 JPY
-1,739,539,000 JPY
Purchase of investment securities
-1,199,000 JPY
-1,200,000 JPY
Net cash provided by (used in) investing activities
-3,116,065,000 JPY
-1,781,833,000 JPY
Cash flows from financing activities
Purchase of treasury shares
-475,000 JPY
JPY
Dividends paid
-974,449,000 JPY
-973,933,000 JPY
Proceeds from long-term borrowings
200,000,000 JPY
JPY
Repayments of long-term borrowings
-737,717,000 JPY
-785,442,000 JPY
Net cash provided by (used in) financing activities
-1,620,462,000 JPY
-1,858,875,000 JPY
Effect of exchange rate change on cash and cash equivalents
3,400,000 JPY
28,239,000 JPY
Net increase (decrease) in cash and cash equivalents
-1,058,016,000 JPY
-640,454,000 JPY
Cash and cash equivalents
9,439,328,000 JPY
10,497,345,000 JPY
11,137,800,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.